Table 2

Expression of adhesion molecules on peripheral blood (PB) and synovial fluid (SF) CD14+monocytes of patients with osteoarthritis, rheumatoid and reactive arthritis. Values show mean (SEM) fluorescence intensity

OsteoarthritisRheumatoid arthritisReactive arthritis
sLeX (CD15s)
 PB109.0 (22.6)431.0 (60.3)2-150 402.9 (61.1)2-150
 SF138.5 (13.8)169.1 (24.3)186.4 (43.0)
LFA-1 (CD11a)
 PB210.9 (7.5)250.5 (21.7) 340.2 (12.3)2-150
 SF189.7 (9.4)213.6 (21.3)194.5 (7.8)
VLA-4 (CD49d)
 PB83.8 (5.2)76.2 (9.6)90.7 (5.0)
 SF122.6 (5.3)93.2 (14.1) 127.0 (7.3)
ICAM-1 (CD54)
 PB51.8 (6.8)47.6 (9.4) 99.2 (24.0)
 SF99.0 (20.7)120.0 (24.1) 217.1 (31.3)2-150
CD44
 PB111.1 (13.2)152.9 (39.3)234.6 (29.3)2-150
 SF270.9 (19.6)382.7 (123.0)470.1 (26.3)2-150
HLA-DR
 PB343.8 (80.1)568.0 (130.5)649.1 (85.3)2-150
 SF1079.5 (187.0)2003.8 (389.8)2-150 2233.0 (136.5)2-150
  • 2-150 Indicates statistically significant difference compared with OA patients. Indicates statistically significant difference between RA and REA (p<0.05).